Literature DB >> 12955405

The dual effects of nitric oxide synthase inhibitors on ischemia-reperfusion injury in rat hearts.

Miyuki Kobara1, Tetsuya Tatsumi, Mitsuo Takeda, Akiko Mano, Satoshi Yamanaka, Jun Shiraishi, Natsuya Keira, Satoaki Matoba, Jun Asayama, Masao Nakagawa.   

Abstract

OBJECTIVE: Nitric oxide (NO) is known to act as a mediator of tissue injury as well as being a potent endogenous vasodilator. The functional and metabolic effects of NO on ischemia-reperfusion injury are still controversial. The aim of this study was to clarify the relationship between the degree of NO synthase (NOS) inhibition and the effects on ischemia-reperfusion injury. METHODS AND
RESULTS: Langendorff-perfused rat hearts were subjected to 30 minutes of global ischemia followed by 30 minutes of reperfusion. The recovery of left ventricular developed pressure (LVDP), creatine kinase (CK) release, and myocardial high energy phosphates were measured in hearts perfused with or without NOS inhibitors, L-N(G)-monomethyl arginine (L-NMMA) or N(G)nitro-L-arginine methylester (L-NAME). NOS inhibitors exerted different effects on the recovery of LVDP and CK release depending on the concentration. The low dose of L-NMMA improved the recovery of LVDP, decreased the CK release during reperfusion, and preserved the myocardial adenosine triphosphate content after reperfusion. In contrast, the high dose of L-NMMA had adverse effects. L-NMMA reduced NO release in coronary effluent in a dose-dependent fashion. Both effects of L-NMMA were abolished by excessive co-administration of L-arginine and the same doses of D-N(G)-monomethyl arginine (D-NMMA) showed no effect on ischemia-reperfusion injury. Therefore, both effects were due to NOS inhibition. In addition, L-NMMA suppressed the myocardial malondialdehyde accumulation, an indicator of oxidative stress, which might be attributed to the beneficial effects by partial NOS inhibition. On the other hand, the high dose L-NMMA significantly decreased coronary fl ow during aerobic perfusion and reperfusion. Therefore, it is conceivable that the vasoactive NOS inhibition contributes to the harmful effects, which might exceed the beneficial effects due to a decrease in oxidative stress.
CONCLUSION: The present results showed that NO inhibitors had dual effects on mechanical function and energy metabolism depending on the concentration. Non-vasoactive inhibition of NOS had beneficial effects due to the suppression of oxidative injury. However, strong vasoactive inhibition of NOS exacerbated the ischemia-reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12955405     DOI: 10.1007/s00395-003-0423-x

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  4 in total

1.  SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts.

Authors:  Jennifer L Strande; Anna Hsu; Jidong Su; Xiangping Fu; Garrett J Gross; John E Baker
Journal:  Basic Res Cardiol       Date:  2007-04-30       Impact factor: 17.165

2.  Post-resuscitation NOS inhibition does not improve hemodynamic recovery of hypoxic newborn pigs.

Authors:  Tze-fun Lee; Corinne N Tymafichuk; Richard Schulz; Po-Yin Cheung
Journal:  Intensive Care Med       Date:  2009-06-24       Impact factor: 17.440

3.  The dose-dependent immunoregulatory effects of the nitric oxide synthase inhibitor N(G)-nitro-L-arginine methyl ester in rats with sub-acute peritonitis.

Authors:  Chien-Chou Hsiao; Chien-Hsing Lee; Lon-Yen Tsao; Hui-Chen Lo
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

4.  Depletion of circulating blood NOS3 increases severity of myocardial infarction and left ventricular dysfunction.

Authors:  Marc W Merx; Simone Gorressen; Annette M van de Sandt; Miriam M Cortese-Krott; Jan Ohlig; Manuel Stern; Tienush Rassaf; Axel Gödecke; Mark T Gladwin; Malte Kelm
Journal:  Basic Res Cardiol       Date:  2013-12-18       Impact factor: 17.165

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.